Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands.
Department of Medicine and Surgery, Circolo Hospital, University of Insubria, Varese, Italy.
Eur J Cardiothorac Surg. 2022 Jan 24;61(2):469-476. doi: 10.1093/ejcts/ezab469.
Papillary muscle rupture (PMR) is a rare but potentially fatal complication of acute myocardial infarction. The aim of this study was to analyse the patient characteristics and early outcomes of the surgical management of post-infarction PMR from an international multicentre registry.
Patients underwent surgery for post-infarction PMR between 2001 through 2019 were retrieved from database of the CAUTION study. The primary end point was in-hospital mortality.
A total of 214 patients were included with a mean age of 66.9 (standard deviation: 10.5) years. The posteromedial papillary muscle was the most frequent rupture location (71.9%); the rupture was complete in 67.3% of patients. Mitral valve replacement was performed in 82.7% of cases. One hundred twenty-two patients (57%) had concomitant coronary artery bypass grafting. In-hospital mortality was 24.8%. Temporal trends revealed no apparent improvement in in-hospital mortality during the study period. Multivariable analysis showed that preoperative chronic kidney disfunction [odds ratio (OR): 2.62, 95% confidence interval (CI): 1.07-6.45, P = 0.036], cardiac arrest (OR: 3.99, 95% CI: 1.02-15.61, P = 0.046) and cardiopulmonary bypass duration (OR: 1.01, 95% CI: 1.00-1.02, P = 0.04) were independently associated with an increased risk of in-hospital death, whereas concomitant coronary artery bypass grafting was identified as an independent predictor of early survival (OR: 0.38, 95% CI: 0.16-0.92, P = 0.031).
Surgical treatment for post-infarction PMR carries a high in-hospital mortality rate, which did not improve during the study period. Because concomitant coronary artery bypass grafting confers a survival benefit, this additional procedure should be performed, whenever possible, in an attempt to improve the outcome.
clinicaltrials.gov: NCT03848429.
乳头肌破裂(PMR)是急性心肌梗死的一种罕见但潜在致命的并发症。本研究的目的是分析国际多中心注册中心数据库中,心肌梗死后 PMR 手术治疗的患者特征和早期结果。
从 CAUTION 研究的数据库中检索到 2001 年至 2019 年间因 PMR 行手术治疗的患者。主要终点为院内死亡率。
共纳入 214 例患者,平均年龄 66.9(标准差:10.5)岁。最常见的破裂部位为后内侧乳头肌(71.9%);67.3%的患者为完全破裂。82.7%的病例行二尖瓣置换术。122 例(57%)患者同时行冠状动脉旁路移植术。院内死亡率为 24.8%。时间趋势分析显示,研究期间院内死亡率无明显改善。多变量分析显示,术前慢性肾脏功能不全(优势比 [OR]:2.62,95%置信区间 [CI]:1.07-6.45,P=0.036)、心脏骤停(OR:3.99,95%CI:1.02-15.61,P=0.046)和体外循环时间(OR:1.01,95%CI:1.00-1.02,P=0.04)与院内死亡风险增加独立相关,而同时行冠状动脉旁路移植术被确定为早期生存的独立预测因素(OR:0.38,95%CI:0.16-0.92,P=0.031)。
心肌梗死后 PMR 的手术治疗院内死亡率较高,且在研究期间并未改善。由于同时行冠状动脉旁路移植术可带来生存获益,因此应尽可能进行该附加手术,以改善预后。
clinicaltrials.gov:NCT03848429。